Clinical features and survival pattern of central nervous system leukemia in children with acute lymphoblastic leukemia
Abstract
Infiltration of leukemic cells into the central nervous system (CNS) is one of the causes of neurological disorders in patients with acute lymphoblastic leukemia (ALL) that worsen the prognosis. This retrospective cohort study aimed to review the clinical manifestations of children with CNS leukemia, their survival pattern and the role of early CNS leukemial. The survival curve was developed by Kaplan-Meier method, while the comparison of survival curves was done with log-rank test. Among 128 new ALL patients, 23 (18.0%) patients suffered from CNS leukemia, while 13 (10.2%) suffered from early CNS leukemia and 10 (7.8%) suffered from relapsing CNS leukemia. CNS leukemia was more common in male, in those aged less than 2 years, in those with white blood cell (WBC) count above 50,000/ìl, and in patients type FAB-L2 ALL. The clinical manifestations most commonly found were decrease of consciousness (61%), vomiting (48%), cranial nerve palsy (44%), seizures (39%), and headache (26%). Relapsing CNS leukemia was more common in high risk (12.5%) compared with standard risk leukemia (5.7%). Patients with early CNS leukemia had a lower survival rate than those without early CNS leukemia (p = 0.0005). The percentage of patients with early CNS leukemia surviving up to 3 years was 26%. We conclude that early CNS leukemia could cause low survival ALL patients.
References
2. Campbell RHA, Marshall WC, Chessels JM. Neurological complications of childhood leukemia. Arch Dis Child 1997; 52:850-8.
3. Abdulsalam M. Diagnosis dan penanggulangan leukemia akut pada anak. In: Wahidiyat I Abdulsalam M, editors. Hematologi anak. Pendidikan tambahan berkala ilmu kesehatan anak. Jakarta: FKUI, 1982; 55-64.
4. Rivera GK, Raimondi SC, Hancock ML, Behm FG, Pui CH, Abromowitch M, et al. Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy. Lancet 1991; 337:61-6.
5. Cohen ME, Duffner PK. Tumors of the brain and spinal cord including leukemic involvement.. In: Swaiman KF, editor. Pediatric neurology principles and practice. 2nd ed. St Louis: Mosby; 1994. p. 931-5.
6. Chessells JM, Bailey C, Richards SM. Intensification treatment and survival in all children with lymphoblastic leukemia: results of UK Medical Research Council Trial UKALL X. Medical Research Council Working on Childhood Leukemia. Lancet 1995; 345:143-8.
7. Abdulsalam M, Zacharia J, Setianingsih I. Kasus leukemia limfoblastik akut pada anak dengan masa hidup 5 tahun. Presented at Kongres Nasional Ilmu Kesehatan anak X (the 10th National Congress of Pediatrics ), Semarang, June 13-17, 1993.
8. Horibe K, Hara J, Yagi K, Tawa A, Komada Y, OdaM, et al. Prognostic factors in childhood acute lymphoblastic leukemia in Japan. Int J Hematol 2000; 72:61-8.
9. Niemeyer CM, Sallan SE. Acute lymphoblastic leukemia. In: Nathan DG, Oski FA, editors. Hematology ofinfancy and childhood. Philadelphia: Saunders, 1993. p. 1249-73.
10. Poplack DG, Reaman G. Acute lymphoblastic leukemia in childhood. Pediatr Clin North Am 1988; 35:903-32.
11. Ekert H. Clinical paediatric haematology and oncology. Melbourne: Anderson, 1982.p. 52-70.
12. Gelber RD, Sallan SE, Cohen HJ, Donnelly M, Dalton V,Tobia F, et al. Central nervous system treatment in childhood acute lymphoblastic leukemia. Cancer 1993; 72:261-70.
13. Behrendt H, Leeuwen EF, Schuwirth C, Verkes RJ, Hermans J, Vanderberg A, et al. The significance of an isolated central nervous system relapse, occurring as first relapse in children with acute lymphoblastic leukemia. Cancer 1989; 63:2066-72
14. Sastroasmoro S, Firmansyah A, Said M, Akib AP Siregar SP. Analisis kesintasan. In: Sastroasmoro S, Ismael S, editors. Dasar-dasar metodologi penelitian klinis. Jakarta:
Binarupa aksara, 1995; 95-108.
15. Saunders BD,. Trapp RG. Basic and clinical biostatistics. Norwalk: Appleton & Lange, 1990. p.186-206.
16. Markum AH, Abdulsalam M, Gatot J, Wahidayat I, Muslichan S. Outcome of CNS leukemia. Paediatr Indones 1980; 20:57–67.
17. Bleyer WA. Central nervous system leukemia. In: Whittaker JA, Delamose IW, editors. Principles and practice of pediatric oncology. 2nd ed . Philadelphia: JB Lippincott Company, 1990. p. 1009-11.
18. Hardisty RM, Norman PM. Meningeal leukaemia. Arch Dis Child 1967; 42:441-7.
19. Aicardi J. Tumours of the CNS and other space occupying lesions. In: Aicardi J, editor. Disease of the nervous system in childhood. London: Mac Keith Press, 1992. p. 817-22.
20. Bray PF. Neurology in pediatrics. Chicago: Yearbook Medical, 1969. p. 263-5.
21. Mellinger JF. Central nervous system involvement in childhood lymphoblastic leukemia. In: Swaiman KF, Wright FS, editors. The practice of pediatric neurology; 2nd ed . St. Louis: Mosby, 1982. p. 817-9.
22. Price RA, Johnson WW. The central nervous system in childhood leukemia: I. the arachnoid. Cancer 1973; 3:520-33.
23. Pollock BH, DeBaun MR, Camitta BM, Shuster JJ, Ravindranath Y, Pullen DJ, et al. Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group Study. J Clin Oncol 2000; 18:813-23.
24. Oakhill A, Mann JR. Poor prognosis of acute lymphoblastic leukemia in Asian children living in The United Kingdom. BMJ 1983; 286:839-41.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Accepted 2016-11-22
Published 2006-10-30